Arsenic trioxide inhibits liver cancer stem cells and metastasis by targeting SRF/MCM7 complex

Hepatocellular carcinoma (HCC) has a high mortality rate due to the lack of effective treatments and drugs. Arsenic trioxide (ATO), which has been proved to successfully treat acute promyelocytic leukemia (APL), was recently reported to show therapeutic potential in solid tumors including HCC. Howev...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hai-Yang, Zhang, Biao, Zhou, Jun-Nian, Wang, Dong-Xing, Xu, Ying-Chen, Zeng, Quan, Jia, Ya-Li, Xi, Jia-Fei, Nan, Xue, He, Li-Juan, Yue, Wen, Pei, Xue-Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560089/
https://www.ncbi.nlm.nih.gov/pubmed/31186405
http://dx.doi.org/10.1038/s41419-019-1676-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560089/
https://www.ncbi.nlm.nih.gov/pubmed/31186405
http://dx.doi.org/10.1038/s41419-019-1676-0

Ejemplares similares